CO-NEWMONT
1.6.2020 15:02:10 CEST | Business Wire | Press release
Newmont Corporation (NYSE: NEM, TSX: NGT) (Newmont or The Company) today announced the publication of its 2019 Sustainability Report, Beyond the Mine , a transparent and comprehensive disclosure of the Company’s environmental, social and governance (ESG) performance.
“Our sustainability report provides investors and other stakeholders a transparent and detailed look at look at our safety, environmental and social performance,” said Tom Palmer, President and Chief Executive Officer. “In 2019, we completed two transformative transactions whilst enhancing our ESG performance to align with our position as the world’s leading gold company.”
Newmont’s 2019 sustainability highlights include:
- Achieving no workplace fatalities and conducting a global safety culture review, which identified several opportunities to enhance Newmont’s Fatality Risk Management program and improve the way fatality risks are managed
- Further strengthening management of tailings, whilst enhancing transparency through a new tailings website with details on all 104 tailings dam facilities at Newmont’s operating sites, joint ventures, subsidiaries and legacy sites
- Reducing greenhouse gas emissions intensity by 13.7 percent, compared to the 2013 baseline, which achieves approximately 83 percent of Newmont’s target to reduce GHG emissions intensity by 16.5 percent by the end of 2020
- Engaging with government, community and contractors to resolve a dispute at the Peñasquito operation in Mexico, which resulted in reaching a 30-year water agreement with the San Juan de Cedros community and signing a memorandum of understanding for an Investment and Social Development Plan that details Newmont’s commitments to the community
- Creating the Global Center for Indigenous Community Relations and the Advisory Council of Canadian and Indigenous Affairs to further enhance Newmont’s global approach to indigenous relations and ensure all commitments to First Nations in Canada and elsewhere are honored
The report also includes an update on Newmont’s efforts – such as protective measures at operating sites and the establishment of a $20 million fund to support communities – to help manage the impacts of the COVID-19 pandemic.
Newmont’s sustainability efforts have been recognized by several independent organizations:
- For the fifth year in a row, Newmont was named the top gold miner in the Dow Jones Sustainability World Index (DJSI)
- Newmont earned a “B” score from CDP for its 2019 Climate Change and Water Security performance
- Newmont was added to the Corporate Human Rights Benchmark’s (CHRB) 2019 evaluation and was ranked 12 th out of more than 200 companies that were assessed against the CHRB’s human rights performance criteria
- For the second consecutive year, Newmont was included in Bloomberg’s Gender-Equality Index (GEI) for its efforts to advance qualified women in the workplace
- Newmont was the top mining company in CR Magazine ’s 100 Best Corporate Citizens list and FORTUNE’s 2020 list of the World’s Most Admired Companies
- Newsweek included Newmont on its first-ever list of America’s Most Responsible Companies for 2020
To meet the needs of both investors and a broader range of stakeholders, Newmont’s 2019 Sustainability Report was written in accordance with the GRI (formerly Global Reporting Initiative) Standards Core option, including the GRI Mining and Metals Sector Supplement, and it follows the Sustainability Accounting Standards Board (SASB) Metals & Mining Sustainability Accounting Standard, the framework preferred by investors. In addition, the report’s climate change information aligns with the Task Force on Climate-related Financial Disclosures (TCFD) reporting guidelines.
Issues and metrics covered in Beyond the Mine were selected based on comprehensive engagement with Newmont employees and leadership; a specially convened panel of global opinion leaders from NGOs, academia and the investor community; and hands-on engagement and reviews with the Safety and Sustainability Committee of Newmont’s Board of Directors.
The report demonstrates Newmont’s commitment to disclosing its performance – including site-level data – on its most material sustainability topics. The full report, along with ESG data tables and a comprehensive GRI/SASB/TCFD content index, is available as a downloadable document on Newmont’s website .
About Newmont
Newmont is the world’s leading gold company and a producer of copper, silver, zinc and lead. The Company’s world-class portfolio of assets, prospects and talent is anchored in favorable mining jurisdictions in North America, South America, Australia and Africa. Newmont is the only gold producer listed in the S&P 500 Index and is widely recognized for its principled environmental, social and governance practices. The Company is an industry leader in value creation, supported by robust safety standards, superior execution and technical proficiency. Newmont was founded in 1921 and has been publicly traded since 1925.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200601005244/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release
First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release
Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures
IHS Towers Publishes 2025 Sustainability Report26.5.2026 12:34:00 CEST | Press release
IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local communities, regulators, governments and shareholders. IHS Towers’ vision is to help create a connected world, where mobile connectivity promotes continued economic growth and social development. The communications infrastructure it provides is vital to enabling that connectivity. In 2025, IHS Towers continued to advance its four-pillar sustainability strategy – focusing on ethics and governance, environment and climate change, education and economic growth, our people and communities – as detailed in this report. Sam Darwi
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 202626.5.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational CO
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
